Max Healthcare Institute Intrinsic Value
Max Healthcare Institute (MAXHEALTH) median intrinsic value is ₹285.51 from 3 valuation models (range ₹286–₹286), vs current price ₹951.70 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit MAXHEALTH stock overview.
MAXHEALTH Valuation Methods Summary — DCF, Graham Number & P/E
Max Healthcare Institute intrinsic value across 3 models vs current price ₹951.70 — upside/downside and value range per method. Browse MAXHEALTH balance sheet details for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹285.51 | ₹228.41 - ₹342.61 | -70.0% | EPS: ₹20.20, Sector P/E: 12x |
| PEG Ratio Method | growth | ₹285.51 | ₹256.96 - ₹314.06 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹285.51 | ₹256.96 - ₹314.06 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
MAXHEALTH Intrinsic Value vs Market Price — All Valuation Models
Max Healthcare Institute fair value range ₹286–₹286 vs current market price ₹951.70 across 3 valuation models. Compare with Max Healthcare Institute value estimation to assess whether the stock is under or overvalued.
MAXHEALTH Intrinsic Value Analysis — Undervalued or Overvalued?
Max Healthcare Institute median intrinsic value ₹285.51, current price ₹951.70 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of MAXHEALTH?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Max Healthcare Institute (MAXHEALTH) is ₹285.51 (median value). With the current market price of ₹951.70, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹285.51 to ₹285.51, indicating ₹285.51 - ₹285.51.
Is MAXHEALTH undervalued or overvalued?
Based on our multi-method analysis, Max Healthcare Institute (MAXHEALTH) appears to be trading above calculated value by approximately 70.0%.
MAXHEALTH Financial Health — Key Ratios vs Industry Benchmarks
Max Healthcare Institute financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Operating Margin | 27.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
MAXHEALTH Cash Flow Quality — Operating & Free Cash Flow
Max Healthcare Institute operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹1,459 Cr | ₹652 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹1,122 Cr | ₹496 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹1,284 Cr | ₹1,233 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹741 Cr | ₹359 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹118 Cr | ₹118 Cr | Positive Free Cash Flow | 8/10 |